Try our Advanced Search for more refined results
July 31, 2023
Paice et al v. Aldeyra Therapeutics, Inc. et al
Case Number:
1:23-cv-11737
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 31, 2023
Mass. Biotech Co. Hit With Stock Drop Suit Over New Drug
Massachusetts-based biotechnology company Aldeyra Therapeutics Inc. was hit with a proposed class action Monday by investors who claim the company and its top executives made false and misleading statements about a cancer treatment in development, causing damage to investors when the drug's revealed ineffectiveness tanked Aldeyra's stock price.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login